Creo Medical, a developer of medical devices, has announced closure of a £3.5 million funding round, led by Finance Wales, angel investors and the Angel CoFund.
The government-backed Angel CoFund joins existing investors Finance Wales, the Arete Angel syndicate and individual business angels, including lead angel Mark Farmer, bringing the total Creo investment received to date to £7.9 million.
This is the second co-investment deal between the Angel CoFund and Finance Wales this year.
Creo Medical has developed medical devices since 2009. This funding will be used for the continuing development of a platform (CROMA) that the company claims will be the first new electrosurgical system in a generation.
Further product developments will focus on providing clinical solutions to complex gastrointestinal problems whilst the platform has further potential in other surgical procedures.
Creo Medical CEO Craig Gulliford said: ‘Since launch, Creo Medical has benefitted significantly from the support both financially and on a business development level, from highly experienced angel investors in the medical and life sciences sectors.
‘Today’s funding announcement marks an important step change for the team, as we focus energies on Europe and the USA. We look forward to working with new investors the Angel CoFund as we concentrate on the next level of growth.’
Tim Mills, investment director of the Angel CoFund added: ‘The Angel CoFund is always on the lookout for both promising British businesses and strong angel investment syndicates, and for us, Creo Medical ticks all the boxes. Craig Gulliford and his team have built a dedicated network of angel investors around Creo and we are delighted to be joining this latest funding round, as Creo set their sights on international expansion.’
Dr Richard Thompson from Finance Wales’ Technology Venture Investments team, who led on the investment for Finance Wales added: ‘The CROMA platform is now attracting exciting commercial and medical interest and we are pleased to follow our investments in Creo Medical.
‘Creo has an impressive group of angel investors and we look forward to working with them and the Angel CoFund to support the company’s international expansion plans. Finance Wales is a long-term backer of Creo which has gone from strength to strength since locating its headquarters in Wales.’
See also: Finance Wales and Angel CoFund invest in IMSPEX Diagnostics
